EXPLORE!

Biologicals for severe asthma.

  984 Views

eMediNexus    05 December 2019

Evidence suggests that the use of biological antibodies is safe in the management of asthma. A new article published in Current Opinion in Allergy and Clinical Immunology reported that after the marketing of monoclonal antibodies, several real-life studies have emerged, which aim to observe how drugs tested only in trials are able to provide adequate effectiveness on real patients. It is known that real-world patients often differ in characteristics from subjects recruited in clinical trials. The authors reported that evidence confirms a good efficacy of biologics in clinical trial subjects as well asreal-life patients, ensuring a promising safety even in periods of observation longer than those of the randomized controlled trials.

To comment on this article,
create a free account.

Sign Up to instantly get access to 10000+ Articles & 1000+ Cases

Already registered?

Login Now

Most Popular Articles

News and Updates

eMediNexus provides latest updates on medical news, medical case studies from India. In-depth medical case studies and research designed for doctors and healthcare professionals.